🔎 Trials Near Me

Hjem › Astma › Colorado

Astma kliniske forsøg i Colorado

18 studier for Astma søger deltagere på steder i Colorado.

Byer i Colorado

Officiel studietekst (engelsk)

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  • GSK Investigational Site, Colorado Springs
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT05757102

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

  • Enveda Investigative Site, Colorado Springs
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 24. sep. 2026 · NCT07301255

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

  • Research Site, Aurora
RekruttererFase 3
Alder 6 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07444567

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  • Asthma & Allergy Associates - Colorado Springs, Colorado Springs
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 22. sep. 2026 · NCT07219173

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Colorado ENT & Allergy, Colorado Springs
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 22. sep. 2026 · NCT06977581

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

  • Research Site 15, Colorado Springs
RekruttererFase 3
Alder 12 til 80 · Alle køn · Opdateret 21. sep. 2026 · NCT07276724

PULmonary Stimulation for Asthma Relief

  • National Jewish Health, Denver
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 16. sep. 2026 · NCT07709754

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  • Teva Investigational Site 12142, Lakewood
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT06664619

A Study of Depemokimab in Participants of 6 to 11 Years of Age

  • GSK Investigational Site, Colorado Springs
RekruttererFase 3
Alder 6 til 11 · Alle køn · Opdateret 26. aug. 2026 · NCT07671001

Registry of Asthma Characterization and Recruitment 3 (RACR3)

  • Children's Hospital Colorado: Allergy Program, Aurora
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alle aldre · Alle køn · Opdateret 21. aug. 2026 · NCT05272241

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

  • GSK Investigational Site, Aurora
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT07456033

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  • Research Site, Denver
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 13. aug. 2026 · NCT06307665

Protocol CAUSE-03 / CHEETAH

  • Children's Hospital Colorado: Allergy Program, Aurora
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 6 til 17 · Alle køn · Opdateret 1. jul. 2026 · NCT06136091

Individualizing Treatment for Asthma in Primary Care (Full Study)

  • DARTNet Institute, Aurora
  • University Colorado-Denver, Aurora
RekruttererFase 4
Alder 13 til 75 · Alle køn · Opdateret 29. okt. 2025 · NCT07052942

Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

  • University of Colorado Anschutz Medical Campus, Aurora
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 10. jun. 2025 · NCT03762395

Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation

  • National Jewish Health, Denver
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 6. apr. 2023 · NCT05259904

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

  • University of Colorado, Aurora
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 2. feb. 2023 · NCT03215836

Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

  • National Jewish Health, Denver
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2017 · NCT02947945

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.